📰 Commodore Capital News
Page 5 - Commodore Capital News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Commodore Capital. Real-time updates on events, politics, business and more.
October 2, 2023
Funding to support clinical advancement of SAB-142, a potential disease-modifying treatment Financing led by RA Capital Management, with participation from BVF Partners, Sessa Capital, Commodore...
September 11, 2023
Commodore Capital LP lifted its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 24.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 575,000 shares of the biotechnology company’s stock after purchasing an additional 112,889 shares during the quarter. […]
September 11, 2023
Commodore Capital LP raised its holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 47.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 790,000 shares of the company’s stock after purchasing an additional 252,924 shares during the quarter. Akero Therapeutics accounts […]
September 11, 2023
Commodore Capital LP boosted its position in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 8.4% in the 1st quarter, HoldingsChannel reports. The fund owned 2,189,659 shares of the company’s stock after acquiring an additional 169,493 shares during the period. Viridian Therapeutics accounts for about 8.5% of Commodore Capital LP’s portfolio, making the […]
September 11, 2023
Commodore Capital LP lifted its position in shares of Merus (NASDAQ:MRUS – Free Report) by 8.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,950,000 shares of the biotechnology company’s stock after acquiring an additional 217,433 shares during the […]
September 11, 2023
Commodore Capital LP acquired a new stake in Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 2,824,029 shares of the company’s stock, valued at approximately $21,914,000. Vera Therapeutics comprises about 3.3% of Commodore Capital LP’s investment portfolio, […]
September 11, 2023
Commodore Capital LP raised its position in Allakos Inc. (NASDAQ:ALLK – Free Report) by 15.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,900,000 shares of the company’s stock after acquiring an additional 256,500 shares during the period. Allakos makes up 1.3% of Commodore Capital LP’s investment […]
September 11, 2023
Commodore Capital LP acquired a new position in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 5,000,000 shares of the biotechnology company’s stock, valued at approximately $3,587,000. Adverum Biotechnologies accounts for 0.5% […]
September 11, 2023
Commodore Capital LP reduced its stake in shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) by 19.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 400,000 shares of the company’s stock after selling 98,315 shares during the period. Commodore Capital LP owned approximately 0.98% of […]
September 11, 2023
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) rose 7.9% during mid-day trading on Monday . The stock traded as high as $15.02 and last traded at $14.95. Approximately 78,930 shares traded hands during trading, a decline of 84% from the average daily volume of 483,739 shares. The stock had previously closed at $13.86. Analysts […]